CLOs on the Move

Alector

www.alector.com

 
Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel therapeutics for Alzheimer`s disease, other forms of dementia, and mechanistically related neurodegenerative disorders. Alector`s strategy is to efficiently generate and validate antibody drugs with unique functional properties that engage key disease-altering targets. This approach is enabled by a strategic alliance with Adimab, the industry leader in discovery and optimization of antibody therapeutics. Alector is currently developing leads for 4 major targets and anticipates taking 2 of these through pre-clinical development and IND enabling studies within 24 months. Alector has incorporated a highly integrated ...
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.alector.com
  • 131 Oyster Point Blvd Suite 600
    South San Francisco, CA USA 94080
  • Phone: 415.231.5660

Executives

Name Title Contact Details
Giacomo Salvadore
Chief Medical Officer Profile
Ja Moon
VP, Healthcare Legal and Compliance Profile
Brian Sander
General Counsel Profile
Kristina Vlaovic
Vice President Regulatory Affairs Profile
Danielle Pasqualone
Vice President, Intellectual Property Profile

Similar Companies

Most Products Inc

Most Products Inc is a Plainwell, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hydrogen Health

Hydrogen Health is a virtual primary care solution that brings K Healths suite of digital healthcare services to employers and health plans, increasing positive long term health outcomes while substantially reducing costs.

Impact Cryotherapy

Impact Cryotherapy is the national leader in designing and manufacturing whole body cryotherapy systems. The company`s state-of-the-art cryosaunas are sleek, attractive single-person chambers that are engineered and manufactured in the United States in an ISO 9001 certified facility. Impact Cryotherapy is redefining the age-old technique of cryotherapy with advanced technology and aesthetics to deliver unmatched efficiency, comfort and reliability.

Technology Commercialization Group

Technology Commercialization Group is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Integrated Diagnostics

At Indi we believe that a systems-based approach is necessary to understand complex diseases and improve health. Our mission is to dramatically improve diagnosis and management of complex diseases by building advanced molecular diagnostics and creating new diagnostic technologies. We seek to understand the complex biological systems from which diseases arise so that we can determine which combinations of biomarkers have the greatest diagnostic power. Then we build assays capable of measuring hundreds of proteins at a time, for more precise detection and management of disease. Our end goal is to create large-scale systems medicine diagnostics that can gather a wealth of information – and then make sense of that information so that physicians can better diagnose disease.